Rapidly lethal dermatomyositis associated with metastatic melanoma [27]

Journal of the European Academy of Dermatology and Venereology

Volumn 22, Issue 3, 2008, Pages 399-401

  Jouary, Thomas ^a,b   Gracia, C ^a,b   Lalanne, N ^a,b   Vital, A ^a,b   Taieb, A ^a,b   Delaunay, M ^a,b  

^a HÔPITAL SAINT ANDRÉ   (France)

^b HÔPITAL PELLEGRIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CORTICOSTEROID; DACARBAZINE; FOTEMUSTINE; GOSERELIN; IMMUNOGLOBULIN; VINDESINE;

AGED; ASTHENIA; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; DEATH; DERMATOMYOSITIS; DISEASE ASSOCIATION; DRUG RESPONSE; DYSPNEA; ELECTRON THERAPY; ERYTHEMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LETHALITY; LETTER; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; MELANOMA; METASTASIS; MYALGIA; PAPULE; PRIORITY JOURNAL; PROSTATE CARCINOMA; RESPIRATORY FAILURE; SKIN SURGERY; TELANGIECTASIA; THERAPY DELAY; WALKING DIFFICULTY;

AGED; DERMATOMYOSITIS; FATAL OUTCOME; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; NEOPLASMS, MULTIPLE PRIMARY; PARANEOPLASTIC SYNDROMES; PROGNOSIS; PROSTATIC NEOPLASMS; SKIN NEOPLASMS;

EID: 39049121556     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2007.02350.x     Document Type: Letter

References (4)

1. Wagner RF, Nathanson L. Paraneoplastic syndromes, tumor markers, and other unusual features of malignant melanoma. J Am Acad Dermatol 1986; 14: 246-249.
2. Schiller M, Bohm M, Hensen P, Riemann H, Luger T, Nashan D. Dermatomyositis associated with malignant melanoma - a marker of poor prognosis? J Am Acad Dermatol 2006; 54: 221-226.
3. Michot C, Dereure O, Baurain JF, Brichard V, Guillot B. Dermatomyositis occurring during treatment of a patient with metastatic melanoma. Melanoma Res 2004; 14: 435-436.
4. Sais G, Marcoval J, Jucgla A, Curco N, Servitje O. Dermatomyositis and malignant melanoma, with complete regression of the primary lesion. Br J Dermatol 1994; 130: 796-797.